Understanding Kcentra and its Nomenclature
Kcentra is a crucial medication primarily used for the urgent reversal of bleeding caused by Vitamin K antagonists (VKAs) like warfarin. Its generic or proper name is Prothrombin Complex Concentrate (Human), often shortened to PCC. Specifically, Kcentra is a 4-Factor Prothrombin Complex Concentrate (4F-PCC). These components help restore the body's ability to clot blood, which is inhibited by warfarin.
International Brand Names and Alternatives
Beyond the U.S. brand name Kcentra, similar 4F-PCC products are available globally under different names, which are important for healthcare professionals to recognize:
- Beriplex: This is the brand name for Kcentra in many European countries and Canada.
- Balfaxar: Approved in the U.S. in 2023, Balfaxar is another 4F-PCC product for urgent warfarin reversal. It's known as Octaplex in Europe and Canada.
- Octaplex: This brand name is used in Europe and other regions for the product known as Balfaxar in the U.S..
- Confidex: This is another international brand name for a 4F-PCC product.
It is important to differentiate these 4F-PCCs from 3-Factor PCCs, which have lower levels of Factor VII and are generally less effective for fully reversing warfarin's effects.
Mechanism of Action and Administration
Kcentra works by quickly replacing the vitamin K-dependent clotting factors depleted by VKAs. This process rapidly enhances the body's ability to form clots and stop bleeding (hemostasis). It is given intravenously, with the dose determined by the patient's weight and their INR level. Vitamin K is often given alongside Kcentra to provide a more lasting effect. A key advantage of Kcentra compared to fresh frozen plasma (FFP) is its smaller volume, faster preparation and administration, and higher concentration of clotting factors.
| Feature | Kcentra (4F-PCC) | Fresh Frozen Plasma (FFP) |
|---|---|---|
| Generic Name | Prothrombin Complex Concentrate, Human | N/A (Blood Product) |
| Active Components | Factors II, VII, IX, X; Proteins C & S | All plasma proteins and clotting factors |
| Administration Time | ~24 minutes (mean) | ~169 minutes (mean, includes thawing) |
| Volume | Low volume (e.g., 20-40 mL per vial) | High volume (typically 200-250 mL per unit) |
| ABO Typing | Not required | Required |
| Primary Use | Urgent reversal of VKA anticoagulation | Broader uses including coagulation factor deficiencies |
Important Safety Considerations
While effective, Kcentra has significant risks, particularly the risk of blood clots (thromboembolic events) such as stroke or pulmonary embolism. A boxed warning highlights this risk, especially in patients already prone to clotting. Kcentra should not be used in patients with a history of heparin-induced thrombocytopenia (HIT) or known allergies to its components. Common side effects can include headache, nausea, vomiting, and low blood pressure.
Conclusion
To answer the question "What is another name for Kcentra?", it is primarily known by its generic name, Prothrombin Complex Concentrate (Human), or more specifically, 4-Factor PCC. This medication is vital for quickly reversing warfarin-induced bleeding. Internationally, it is sold as Beriplex, and similar 4F-PCC products include Balfaxar and Octaplex. Kcentra offers advantages over FFP in terms of speed and volume but carries a notable risk of blood clots, requiring careful patient assessment.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a qualified healthcare professional for any medical concerns or before making any decisions related to your health or treatment.
{Link: CSL Behring https://www.cslbehring.com/}
